Partial Nephrectomy in Clinical T1b

Objective
To evaluate perioperative results of open (OPN), laparoscopic (LPN), and robot-assisted partial nephrectomies (RAPN) and to identify predictive factors of Trifecta achievement for clinical T1b renal tumors in a multicenter prospective dataset.
Methods
Data of 285 patients who had OPN (133), LPN (57), or RAPN (95) for cT1b renal tumors were extracted from the RECORd Project. High-volume centers were defined as ≥50 overall cases of partial nephrectomy per year. Trifecta was defined as simultaneous absence of perioperative complications, negative surgical margins, and ischemia time <25 minutes.
Results
The 3 groups had comparable body mass index, preoperative hemoglobin, creatinine and estimated glomerular filtration rate, tumor clinical diameter, and growth pattern. LPN and RAPN were more frequently exclusive of high-volume centers. RAPN showed significantly lower median estimated blood loss compared with OPN and LPN. Trifecta was achieved in 62.4%, 63.2%, and 69.5% of OPN, LPN, and RAPN (P = NS) cases. Median warm ischemia time (WIT) was significantly shorter during OPN than during LPN and RAPN. RAPN had significantly shorter WIT compared with LPN. RAPN was significantly less morbid than OPN regarding intraoperative and postoperative complications. LPN (1.9%) and RAPN (2.5%) showed a lower rate of positive margins compared with OPN (6.8%) (P = NS). At multivariable analysis, exophytic tumor growth pattern, estimated blood loss, and high-volume centers were significant predictive factors for Trifecta achievement.
Conclusion
Clinically, T1b renal tumors suitable for NSS can be safely treated by LPN or RAPN in highvolume centers. RAPN allows for significantly lower WIT and estimated blood loss with higher rate of Trifecta achievement compared with LPN.
Partial nephrectomy (PN) is nowadays strongly recommended by international guidelines when considering surgical treatment of small renal masses cT1 staged.
1 and 2 Goals of PN are negative cancer margin, minimal renal functional decrease, and avoidance of complications. In latest years, these goals are together constituting "Trifecta", a concept taken from radical prostatectomy's literature now introduced in surgery for renal cancer to standardize reporting of PN outcomes. Trifecta is achieved when warm ischemia time (WIT) less than 25 minutes, negative surgical margins, and no perioperative complications are simultaneously realized. 3, 4 and 5 For many years, open PN (OPN) has been considered the "gold standard" but since advancements in laparoscopic techniques, equipment, and operator skills, laparoscopy has been becoming more and more commonly used, 2 as offering comparable oncological outcomes, less morbidity, and shortened convalescence. 2, 6, 7, 8 and 9 As such, for clinical T1a lesions, surgical removal choosing a minimally invasive approach is nowadays well established.
In patients with larger renal masses, the role of PN is less well established. In fact, European Association of Urology Guidelines support routine use of nephron sparing surgery (NSS) also for T1b tumors as it affords conservation of normal renal parenchyma, even preserving oncologic efficacy. Conversely, American Urological Association Guidelines support radical nephrectomy as standard of care in patients with major comorbidity or high surgical risk and suggest NSS as an alternative standard of care only in healthy patients, particularly when there is a need to preserve renal function.
1 and 2 Several recent population reviews together with smaller single or multiinstitutional studies have showed that the cancer-specific survival is similar in patients undergoing partial or radical nephrectomy for T1b lesions. 6, 7, 8, 10, 11 and 12 Moreover, NSS for renal masses greater than 4 cm seems to be able to provide additional functional benefits and lower incidence of cardiovascular morbidities in the long-term period.
13
In these larger lesions, the use of a minimally invasive approach is less adopted. Indeed, laparoscopic PN (LPN) is a technically challenging procedure and it is still often confined in the hand of a few expert surgeons in tertiary centers. In recent years, the widespread diffusion of robotic system has bridged the technical difficulties of LPN leading to a broader choice of minimally invasive approach to larger renal masses by robot-assisted PN (RAPN). 14, 15 and 16 To date, no study has compared the perioperative outcome of T1b renal tumors after the 3 currently available surgical options, namely, OPN, LPN, and RAPN. With this purpose, we designed the present multicenter comparative study. Analysis was specifically aimed to intraoperative and perioperative data. The secondary aim of the study was to perform a univariate and multivariable analysis looking for predictive factors of Trifecta achievement. . High-volume centers were defined as ≥50 overall cases of PN per year. Surgeons were all skilled in performing either RAPN, LPN, or OPN. Clinical staging included abdominal computed tomography (CT) and chest CT or X-rays. Magnetic resonance imaging was used in a few patients as an alternative to CT. Bone scans and brain CT were obtained only when indicated by the signs and symptoms. Open procedures were performed using mainly a flank retroperitoneal approach. Tumor excision was done by clamping the renal pedicle or with no clamping, using manual compression of the surrounding renal parenchyma. Opened calyces and bleeding sites were sutured and the parenchymal defect was closed with horizontal interrupted sutures with or without the application of hemostatic agents (FloSeal, Baxter Healthcare; Tachosil, Nycomed; Tabotamp, Ethicon) . Minimally invasive laparoscopic and robotic procedures were performed using either a transperitoneal or a retroperitoneal approach according to surgeon's and center's preferences. Tumor excision was done by warm ischemia or with a clampless procedure. An early unclamping after parenchymal sutures on the tumor bed was adopted when indicated. The parenchymal defect was repaired using the sliding-clip technique. Hemostatic agents were used in most cases before cortical closure.
Methods
Data Collection
All the variables recorded were prospectively collected in an online controlled database. Estimated glomerular filtration rate (eGFR) The complications up to 3 months after surgery were classified according to the Dindo modification of the Clavien system and to the European Association of Urology standardized quality criteria on reporting PN surgical complications.
22 and 23 Trifecta outcome was defined as simultaneous achievement of WIT <25 min, absence of complications, and negative surgical margin as suggested by Khalifeh et al. 3 The hemoglobin and eGFR at 1 and 3 days after surgery were collected and the differences between preoperative and postoperative values were calculated.
Statistical Analyses
Continuous parametric variables were reported as the mean ± standard deviation (SD), whereas nonparametric variables were reported as the median and interquartile range (IQR). The MannWhitney U-test and unpaired Student's t-test were used to compare continuous variables, as appropriate. Categorical variables are reported as frequencies and proportions. Pearson's chi-square test was used to compare categorical variables. A univariate and multivariable logistic regression was performed for Trifecta outcome. For all statistical analyses, a two-sided P <.05 was considered statistically significant. Analyses were performed using SPSS version 20.0 (SPSS Inc., Chicago, IL).
Results
Overall, 133 OPN, 57 LPN, and 95 RAPN were analyzed. Preoperative data are reported in Table 1 . Median (IQR) clinical tumor diameter was 5.0 (4.3-5.5) cm and 63% of tumors were mainly exophytic. The 3 groups had comparable body mass index, preoperative hemoglobin, creatinine, eGFR, tumor clinical diameter, and tumor growth pattern (Table 2) . Females were more represented in RAPN group (55.8%) compared with LPN group (26.3%; P = .01) ( Table 2) . Patients undergoing RAPN were significantly younger (mean age of 57.3 years; SD 15.1 years) compared with patients in OPN group (mean age of 62.3 years; SD 13.8 years; P = .01) ( Table 2 ). Tumors in the LPN group showed a significantly higher mesorenal location (40.4%) compared with those of OPN group (24.8%; P = .03) ( Table 2) . Creat preoperative, median IQR 0,9 0.7-1.1 1.0 0.9-1.0 1.0 0. Table options A comparison of intra-and postoperative outcomes among open, laparoscopic, and robot-assisted approach is reported in Table 3 . The minimally invasive approaches, either pure laparoscopic or robot assisted, were more frequently exclusive of high-volume centers; indeed, 93% of LPN and 100% of RAPN were in those centers with high caseload. LPN and RAPN showed a lower rate of positive surgical margins (SM) compared with OPN, 1.9%, 2.5%, and 6.8% respectively, although not reaching the statistical significance.
Trifecta was achieved in 62.4%, 63.2%, and 69.5% for OPN, LPN, and RAPN, respectively, with no statistical differences among the groups.
Median (IQR) third postoperative day (POD) hemoglobin drop was significantly lower in LPN (1.0; 0.2-3.0) with respect to OPN (2.0; 1.7-3.0) (P = .003) and RAPN (2.4; 1.4-3.0) (P = .01) groups. Median (IQR) first POD eGFR drop was higher in OPN (15.2; 0.0-28.5) group with respect to LPN group (5.2; 0.0-16.7) (P = .02) and to RAPN group (1.2; 0.0-12.6) (P < .0001). No differences among the groups were found when comparing median eGFR drop at the third POD and at 30th POD.
When performing univariate analysis ( Nevertheless, no consensus has been reached yet about the best approach for the treatment of renal tumors greater than 4 cm in size. Available literature states that for T1b tumors, PN should be performed whenever technically feasible and the open approach is still the gold standard. 1 and 2 LPN is the alternative to OPN in tertiary referral centers, but it is associated with longer WIT and higher complication rates. 26 Initial experiences with RAPN show an overall, recurrence-free, and cancerspecific survival in T1b tumors comparable with OPN at a 2-year median follow-up 16 and a trend toward a lower WIT respect to LPN.
27 Indeed, the introduction of robotic system, thanks to the advantages of magnified stereoscopic visualization and the articulated instruments, has reduced the technical challenges associated with tumor dissection and renorraphy, overcoming the limitations of pure laparoscopic approach.
A few studies focused on the outcomes of RAPN for T1b renal lesions up to date: initial experiences underlined a significant higher WIT in T1b compared with T1a renal tumors, unsupported by significant difference between two groups in terms of functional outcomes and complications.
28 and 29 None of the published studies is offering a simultaneous comparison among the three surgical approaches to T1b lesions.
Indeed, without a significant difference of preoperative patients and tumor selection between three groups (except for a significantly higher rate of mediorenal lesions in LPN compared with OPN and a statistically but not clinically significant age difference between RAPN and OPN), Trifecta was achieved in 69.5%, 63.2%, and 62.4% of RAPN, LPN, and OPN. The robotic approach was able to significantly reduce WIT in comparison with the pure laparoscopic approach and to significantly reduce intraoperative and postoperative complications in comparison with the standard open approach with a similar positive SM rate in comparison with LPN but lower than OPN although not reaching the statistical significance.
The most possible explanations of reduced complications in robotic approach are attributable to the elevated experience of robotic surgeons that were not in their learning phase (also clear by the fact that we are analyzing cT1b tumors), and to the benefits of minimally invasive surgery in addition to the improved dexterity and vision of robotic system that makes open surgery actions replicable with a robotic approach. Furthermore, the reduced PSM rate in LPN and RAPN in comparison with OPN is considered as an important pointer that minimally invasive surgery is feasible and safe in the treatment of clinical T1b renal tumors.
Clampless procedures were significantly higher in minimally invasive approaches; this could be related to the high-definition view along with the increased abdominal pressure related to the pneumoperitoneum that allows a higher control of bleeding during the excision of renal tumor and permit the surgeon to perform clampless procedure with greater peace of mind. Robotic approach presented a significantly lower rate of clampless compared with LPN, probably for the absence of tactile feedback that requires a perfect visual control in a bloodless field.
Indeed, lowest EBLs were registered with RAPN: this difference, although not clinically relevant, was surely due to a precise microdissection of vasculature of renal pedicle and magnified intraoperative vision that limits bleeding and allows for selective immediate coagulation but also to the significantly lower rate of clampless procedures in the RAPN group.
For the secondary purpose of the study, we performed a univariate and multivariable analyses. The three approaches were again compared concerning the rate of Trifecta achievement.
The trifecta outcome represents a modern standardized tool to evaluate the quality of NSS and to more easily compare different approaches with PN. Trifecta is accomplished if the three key outcomes of negative cancer margin, minimal renal functional decrease expressed as WIT <25 minutes and no surgical complications are simultaneously realized.
3, 4 and 5 Intra-operative EBL and volume center were the most important factors in predicting the likelihood of achieving Trifecta, whereas the surgical approach was not a predictor of a positive trifecta at univariate analysis. At multivariable analysis, the same factors together with tumor growth pattern were found to be independent predictors of Trifecta achievement.
The study was not devoid of limitations. Different surgeons were involved and this could potentially influence the results. However, this might have increased the external validity of the data with respect to a single-center or single-surgeon setting.
Another limit is the lack of standardized anatomical information in the RECORD 1 database generated in 2008 before the publication of the available published nephrometric systems. However, the surgical complexity of renal masses was in any case evaluated by the present study according to multiple variables, as tumor location and growth pattern.
Moreover, in centers with minimally invasive expertise, open approach is nowadays reserved to imperative indications and very challenging tumors alone, unsuitable for a minimally invasive approach, thereby leading to a potential worsening of the outcomes of such an approach for tumors over 4 cm. In the present study, the inclusion of centers with different surgical volumes and of centers with no minimally invasive experience might have overcome this bias.
Nevertheless, the very low proportion of cases coming from low volume centers, treated exclusively by open PN, shows how the indication to PN for T1b tumors is reserved to high-volume centers and still needs to be supported to become a standard vs radical nephrectomy. Conversely, the inclusion of tertiary referral centers for LPN might have improved the results of such an approach acting as a possible confounder in comparing LPN with the other approaches.
We recognize that a randomized-controlled trial would be required to draw definitive conclusions about the gold standard approach for PN in T1b renal tumors.
Notwithstanding these limitations, to the best of our knowledge, this paper would represent a unique report with the worship of a simultaneous comparison of outcomes of all different approaches with NSS for clinically T1b renal tumors.
Conclusion
The present study demonstrated that patients with clinically T1b renal tumors suitable for NSS can be safely treated by a minimally invasive approach either by LPN or RAPN in high-volume centers. If available, robotic approach allows for significantly lower WIT and EBL with higher rate of Trifecta achievement compared with LPN. 
